Bipolar Disorder Drugs and Treatment Market to 2035 Driven by Demand for Novel Therapies with Improved TolerabilityApril 3, 2026
Share Twitter Facebook LinkedIn Email Masayuki Omoto, President and CEO at Marubeni, discusses the trading house’s business strategy and the impact from the US trade tariffs. He speaks with Shery Ahn and Haidi Stroud-Watts on “Bloomberg: The Asia Trade”. (Source: Bloomberg)Read More
Small business in Los Gatos remembers Loma Prieta earthquake, thankful for no damage in Thursday’s quakeApril 3, 2026
For the First Time, This U.S. Airline Will Offer Business Class on International FlightsApril 3, 2026